Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12834395 | 0.91 | KDM1A (0.32) | ALDH1A1KDM1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16270061 | 0.88 | ALDH1A1 (0.34) | HPGDALDH1A1KDM1ASLC6A2SLC6A4 | |
| SCHEMBL12834379 | 0.88 | GRIN1 (0.31) | GRIN1GRIN2B | |
| SCHEMBL1509899 | 0.88 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL13026076 | 0.88 | GAA (0.31) | HPGDSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13026113 | 0.88 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL13026084 | 0.85 | — | — | |
| SCHEMBL16638478 | 0.85 | ALDH1A1 (0.35) | ALDH1A1KDM1A | |
| SCHEMBL12833697 | 0.84 | CTSL (0.33) | GRIN1GRIN2B | |
| SCHEMBL12834715 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1731493-B1 | BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | CHISSO CORP (JP) | 2011-03-23 | — | — | EP | disclosed |